We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Contaminated Heparin Remains Key GMP Concern for FDA
Contaminated Heparin Remains Key GMP Concern for FDA
October 10, 2011
The contaminated heparin crisis from years back that affected device- and drugmakers “could still be happening” and the FDA continues to focus some of its limited resources on keeping the fake anticoagulant out of the U.S. drug supply.